ARAdriana Cristina Camargos de Rezende

Adriana Cristina Camargos de Rezende

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Adriana Cristina Camargos de Rezende has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Localized Cutaneous Versus Deep Sporotrichosis at Hospital das Clínicas, UFMG, Belo Horizonte, Brazil: A Cohort of 213 Culture-Confirmed Cases, 2011 to 2026

    by Helena Duani, Frederico Figueiredo Amâncio, Alexandre Soares Bifano, Vitória Baltazar Mattos, Kaique Veloso Silva, Beatriz Vieira Melo, Heloisa Filipe Pascoal, Rafael Lima Sendin, Marcus Vinicius Carvalho Akerman, Felipe Torreão Corrêa Thiemann, et al.

    Background: The zoonotic epidemic of sporotrichosis caused by Sporothrix brasiliensis has expanded throughout Brazil and other countries, with a rise in deep forms of disease. Detailed comparative data on the presentation, treatment and outcomes of cutaneous and deep disease are needed to follow how Brazilian cohorts are evolving. Methods: The study involves a retrospective observational cohort of patients with sporotrichosis treated at a quaternary university hospital in Belo Horizonte between 2011 and 2026, restricted to culture-positive cases. Localized cutaneous disease was compared with deep infection using logistic regression adjusted for age and sex. Results: Of 313 patients, 213 had a positive culture. The median age was 41 years, and 54.0% were women. Lymphocutaneous disease predominated (54.0%), and contact with cats was reported by 53.1%. The median treatment duration was 150 days. Among the 101 patients with a defined outcome, 97 were cured (96.0%), with no documented treatment failure. All four sporotrichosis-related deaths occurred in the deep infection group, which was independently associated with comorbidity (OR 9.69; 95% CI 2.52 to 37.23) and an immunosuppressive condition (OR 6.61; 95% CI 1.89 to 23.09). Conclusions: Localized cutaneous sporotrichosis was cured in nearly all the patients with documented follow-up, whereas mortality was confined to deep infection associated with comorbidities and immunosuppression.

  • Open Access

    Localized Cutaneous Versus Deep Sporotrichosis at Hospital das Clínicas, UFMG, Belo Horizonte, Brazil: A Cohort of 213 Culture-Confirmed Cases, 2011 to 2026

    by Helena Duani, Frederico Figueiredo Amâncio, Alexandre Soares Bifano, Vitória Baltazar Mattos, Kaique Veloso Silva, Beatriz Vieira Melo, Heloisa Filipe Pascoal, Rafael Lima Sendin, Marcus Vinicius Carvalho Akerman, Felipe Torreão Corrêa Thiemann, et al.

    Background: The zoonotic epidemic of sporotrichosis caused by Sporothrix brasiliensis has expanded throughout Brazil and other countries, with a rise in deep forms of disease. Detailed comparative data on presentation, treatment and outcome of cutaneous and deep disease are needed to follow how Brazilian cohorts are evolving. Methods: Retrospective observational cohort of patients with sporotrichosis treated at a quaternary university hospital in Belo Horizonte between 2011 and 2026, restricted to culture-positive cases. Localized cutaneous disease was compared with deep infection using logistic regression adjusted for age and sex. Results: Of 313 patients, 213 had a positive culture. Median age was 41 years and 54.0% were women. Lymphocutaneous disease predominated (54.0%) and contact with cats was reported by 53.1%. Median treatment duration was 150 days. Among the 101 patients with a defined outcome, 97 were cured (96.0%), with no documented treatment failure. All four sporotrichosis-related deaths occurred in the deep infection group, which was independently associated with comorbidity (OR 9.69; 95% CI 2.52 to 37.23) and with an immunosuppressive condition (OR 6.61; 95% CI 1.89 to 23.09). Conclusions: Localized cutaneous sporotrichosis was cured in nearly all patients with documented follow-up, whereas mortality was confined to deep infection associated with comorbidity and immunosuppression.